Literature DB >> 1839030

Expression of immunoglobulin genes in common variable immunodeficiency.

H Kaneko1, N Kondo, F Motoyoshi, S Mori, Y Kobayashi, Y Inoue, T Orii.   

Abstract

Five common variable immunodeficiency (CVI) patients were analyzed for expression of immunoglobulin (Ig) genes. In the pokeweed mitogen (PWM)-induced Ig-production assay, the combination of T and B cells showed that all patients' T cells had normal helper functions and all patients' B cells had profound defects. The defective B-cell maturation stages based on their Ig gene expression patterns were variable. One of five patients showed normal mu-chain gene expression and nearly normal IgM production, but neither IgG nor IgA production, which suggested that this patient's B-cell defects might lie on a mu- to gamma or mu- to alpha class-switch stage. B cells in another patient showed low mu-chain gene expression and low IgM production, but an Ig enhancer region, which is an important region for expression of Ig genes, was intact. Thus, this patient might have a transacting factor defect which interacts with the Ig enhancer region. The other three patients showed no mu-chain gene expression and no IgM production. Thus, their B-cell defects lay on the B-cell maturation stage, similar to X-linked agammaglobulinemia. These results showed that primary B-cell defects in CVI occurred at several B-cell differentiation stages, which could be recognized by expression of Ig genes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1839030     DOI: 10.1007/bf00918184

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  31 in total

1.  Selective IgG deficiency with a transcriptional disorder of the gamma switching region gene and the IL-4 gene.

Authors:  H Kaneko; M Nakashima; A Kudo; R Iwakiri; M Harada; T Watanabe
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

2.  B cell function in acquired "common-variable" hypogammaglobulinemia: proliferative responses to lymphokines.

Authors:  J Farrant; A Bryant; F Almandoz; G Spickett; S W Evans; A D Webster
Journal:  Clin Immunol Immunopathol       Date:  1989-05

3.  Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency.

Authors:  M C Sneller; W Strober
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

4.  Role of interleukin-2 and interleukin-6 in the mitogen responsiveness of T cells from patients with 'common-variable' hypogammaglobulinaemia.

Authors:  M E North; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

5.  Two regulatory elements for immunoglobulin kappa light chain gene expression.

Authors:  Y Bergman; D Rice; R Grosschedl; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

6.  Cloning of human immunoglobulin mu gene and comparison with mouse mu gene.

Authors:  N Takahashi; S Nakai; T Honjo
Journal:  Nucleic Acids Res       Date:  1980-12-20       Impact factor: 16.971

7.  Nuclear factors binding to the human immunoglobulin heavy-chain gene enhancer.

Authors:  H Maeda; K Araki; D Kitamura; J Wang; T Watanabe
Journal:  Nucleic Acids Res       Date:  1987-04-10       Impact factor: 16.971

8.  The V(D)J recombination activating gene, RAG-1.

Authors:  D G Schatz; M A Oettinger; D Baltimore
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

9.  Correction of the molecular defect in B lymphocytes from X-linked agammaglobulinemia by cell fusion.

Authors:  J Schwaber; N Koenig; J Girard
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

10.  Retinoic acid induces the differentiation of B cell hybridomas from patients with common variable immunodeficiency.

Authors:  E Sherr; D C Adelman; A Saxon; M Gilly; R Wall; N Sidell
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  4 in total

Review 1.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

2.  Expression of Pax5 gene in human haematopoietic cells and tissues: comparison with immunodeficient donors.

Authors:  H Kaneko; T Ariyasu; R Inoue; T Fukao; K Kasahara; T Teramoto; E Matsui; S Hayakawa; N Kondo
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Defective CD2 T cell pathway activation in common variable immunodeficiency (CVID).

Authors:  S Zielen; T J Dengler; P Bauscher; S C Meuer
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

Review 4.  Common variable immunodeficiency.

Authors:  W Strober; K Chua
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 10.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.